Skip to main content

Table 1 Antimicrobial susceptibility of CERI, VAN, OXA and daptomycin against Gram-positive and Gram-negative pathogens

From: Insights into the antimicrobial effects of ceritinib against Staphylococcus aureus in vitro and in vivo by cell membrane disruption

Strain

CERI (μg/ml)/(μM)

VAN (μg/ml)

DAP (μg/ml)

OXA (μg/mL)

MIC

MBC

MIC

MBC

MIC

MBC

MIC

MBC

S. aureus

 ATCC 25923

16/28.67

32/57.33

1

1

1

4

0.5

2

 ATCC 29213

16/28.67

64/114.67

2

4

0.5

1

0.25

2

 ATCC 43300

16/28.67

32/57.33

2

4

0.5

1

32

32

 Newman

16/28.67

32/57.33

2

1

1

2

< 0.125

2

 SAJ1

16/28.67

32/57.33

4

4

2

2

> 64

> 64

 LZB1

16/28.67

16/28.67

1

2

0.5

1

0.25

0.5

 RJ-2

16/28.67

32/57.33

1

2

0.5

1

8

32

 USA 300

 > 128/ > 229.33

 > 128/ > 229.33

2

8

0.5

8

16

16

 SA0524

16/28.67

16/28.67

2

8

1

1

8

8

 SA2231

16/28.67

16/28.67

2

2

0.5

1

8

8

E. faecalis

 ATCC 29212

16/28.67

 > 128/ > 229.33

4

16

4

8

E. coli

 ATCC 25922

 > 128/ > 229.33

 > 128/ > 229.33

> 128

> 128

> 128

> 128

K. pneumoniae

 ATCC 700603

 > 128/ > 229.33

 > 128/ > 229.33

> 128

> 128

> 128

> 128

A. baumannii

 ATCC 1195

 > 128/ > 229.33

 > 128/ > 229.33

> 128

> 128

> 128

> 128

 MDR 1208

 > 128/ > 229.33

 > 128/ > 229.33

> 128

> 128

> 128

> 128

 MDR 1069

 > 128/ > 229.33

> 128/ > 229.33

> 128

> 128

 > 128

> 128

P. aeruginosa

 PAO1

 > 128/ > 229.33

> 128/ > 229.33

> 128

> 128

> 128

> 128